Researchers at the Dana-Farber Cancer Institute, led by former Damon Runyon Clinical Investigator Eliezer M. Van Allen, MD, PhD, have built an experimental artificial-intelligence tool designed to hel...

The Damon Runyon Cancer Research Foundation has named 14 new Damon Runyon Fellows, brilliant postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading s...

Purines, namely adenine and guanine, are one of two chemical compounds that cells use to make the building blocks of DNA and RNA. (The other are pyrimidines, cytosine and thymine.) Cells can make puri...

Acute myeloid leukemia (AML) is diagnosed in more than 20,000 people in the U.S. each year, and the five-year survival rate remains around 30%. For patients whose disease is driven by mutations in the...

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading...

Damon Runyon scientists and industry partners gathered on Tuesday, March 24, for the 2026 Accelerating Cancer Cures Research Symposium, hosted by Amgen in Cambridge, Massachusetts.

Cancer drugs often target a molecule that cancer cells rely on for survival but, crucially, healthy cells do not. When they are first identified, this type of molecule is known as a therapeutic vulner...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2026 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to...

Current and former Damon Runyon scientists explain why breakthroughs can come from unusual places, and why Damon Runyon's funding strategy is so important.…

In 2021, Damon Runyon scientists Michael E. Pacold, MD, PhD, Robert S. Banh, PhD, and their colleagues at New York University Langone Health discovered how the enzyme CoQ10 is made, a synthesis pathwa...

Damon Runyon scientists explain how drastic cuts in federal research funding threaten progress in cancer research, and how Damon Runyon can help protect the breakthroughs…

New research from Damon Runyon-Dale F. Frey Breakthrough Scientist Abigail E. Overacre-Delgoffe, PhD, and her lab at the University of Pittsburgh suggests that sucralose—the sugar substitute found in ...

Damon Runyon scientists explain what your support has meant during a difficult year for cancer researchers. Help protect their progress in 2026 at at damonrunyon.org.

Learn more about our brilliant young scientists and support their work at damonrunyon.org.

The National Academy of Medicine has announced 100 new members for the Class of 2025.

Since the Food and Drug Administration approved the targeted therapy drug venetoclax in 2020, it has become a first-line treatment for acute myeloid leukemia (AML), a blood cancer. Unfortunately, some...

Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of...

Decreased brain coenzyme Q10 levels cause encephalopathy and are associated with neurodegeneration; supplementation with 4-HMA or 4-HB restores coenzyme Q10 synthesis in mice and humans with HPDL vari...

Experience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston.

Arv streams Day 2 of ArvCon 2025--By The Dice Roll with D&D: Ghosts of Saltmarsh! !donate !arvcon !drcrf !BLM !ukraine